124 related articles for article (PubMed ID: 1362418)
1. Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.
Bone HG; Deftos LJ; Snyder WH; Pak CY
Henry Ford Hosp Med J; 1992; 40(3-4):258-60. PubMed ID: 1362418
[TBL] [Abstract][Full Text] [Related]
2. Impact of prospective screening for multiple endocrine neoplasia type 2.
Gagel RF; Tashjian AH; Cummings T; Papathanasopoulos N; Reichlin S
Henry Ford Hosp Med J; 1987; 35(2-3):94-8. PubMed ID: 2891654
[No Abstract] [Full Text] [Related]
3. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
[No Abstract] [Full Text] [Related]
5. Characteristics of a family with the MEN-2A syndrome.
Haak HR; Nieuwenhuijzen Kruseman AC
Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
[No Abstract] [Full Text] [Related]
6. Results of a screening program for multiple endocrine neoplasia type II.
Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
[TBL] [Abstract][Full Text] [Related]
7. Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery.
Lips CJ; Leo JR; Berends MJ; Minder WH; Blok AP; Geerdink RA; Hackeng WH; Roelofs JM; Vasen HF; Vette JK
Henry Ford Hosp Med J; 1987; 35(2-3):133-8. PubMed ID: 2891645
[No Abstract] [Full Text] [Related]
8. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
9. [Use of plasma calcitonin levels in the detection of Sipple syndrome in siblings (clinicopathological conference)].
Bürgi H; Burckhardt P; Gardiol D
Schweiz Med Wochenschr; 1982 Dec; 112(50):1820-5. PubMed ID: 6130600
[TBL] [Abstract][Full Text] [Related]
10. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
11. Hereditary endocrine tumors.
Melmed S
Curr Ther Endocrinol Metab; 1994; 5():576-8. PubMed ID: 7704796
[No Abstract] [Full Text] [Related]
12. [The clinical characteristics and therapy of multiple endocrine neoplasia type 2].
Xie Y; Li HZ; Rong S; Zhu Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1096-9. PubMed ID: 15498294
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
Oishi S; Sasaki M; Sato T; Isogai M
Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
[TBL] [Abstract][Full Text] [Related]
14. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
Pati M; Sperti P; Magiar AV; Bonifacio V
Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 2B: eighteen-year follow-up of a four-generation family.
Sizemore GW; Carney JA; Gharib H; Capen CC
Henry Ford Hosp Med J; 1992; 40(3-4):236-44. PubMed ID: 1362413
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
17. [Multiple endocrine neoplasia II A syndrome: relationship between age of the patient, levels of basal calcitonin and size of the thyroid tumor].
Parrilla P; Candel MF; Ponce JL; Tebar J; Albarracin A; Rodriguez JM
Minerva Chir; 1992 May; 47(9):831-8. PubMed ID: 1352395
[TBL] [Abstract][Full Text] [Related]
18. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.
Gagel RF; Tashjian AH; Cummings T; Papathanasopoulos N; Kaplan MM; DeLellis RA; Wolfe HJ; Reichlin S
N Engl J Med; 1988 Feb; 318(8):478-84. PubMed ID: 2893259
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
20. [Medullary cancer of the thyroid gland].
Chabloz R; Bischoff T; Saraga P; Loosli H; Scazziga B; Burckhardt P; Saegesser F
Schweiz Med Wochenschr; 1983 Jun; 113(22):814-23. PubMed ID: 6136090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
